![Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia – TIF Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia – TIF](https://thalassaemia.org.cy/wp-content/uploads/2020/10/Untitled-design-39.png)
Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia – TIF
![A Leading Clinical-stage Biopharmaceutical Company in USA Undertakes Procurement Transformation with Zycus A Leading Clinical-stage Biopharmaceutical Company in USA Undertakes Procurement Transformation with Zycus](https://www.zycus.com/images/Assets-Images/Case-Study/Kh-A-Leading-Clinical-stage-Biopharmaceutical-Company-in-USA.jpg)
A Leading Clinical-stage Biopharmaceutical Company in USA Undertakes Procurement Transformation with Zycus
Elpiscience Announces First Patient Dosed in Phase 1/2 Clinical Study of ES104 for Treatment of Colorectal Cancer
![Eyenovia, Arctic Vision to Develop and Commercialize MicroPine and MicroLine in Asia - Review of Myopia Management Eyenovia, Arctic Vision to Develop and Commercialize MicroPine and MicroLine in Asia - Review of Myopia Management](https://reviewofmm.com/wp-content/uploads/2020/08/GettyImages-1150260579-300x180.jpg)
Eyenovia, Arctic Vision to Develop and Commercialize MicroPine and MicroLine in Asia - Review of Myopia Management
![Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products](https://www.pharmaadvancement.com/wp-content/uploads/drug-development/14741/sanfoiGSK.jpg)
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
![e How much is your compound worth? Biopharmaceutical company valuation... | Download Scientific Diagram e How much is your compound worth? Biopharmaceutical company valuation... | Download Scientific Diagram](https://www.researchgate.net/publication/277026797/figure/fig3/AS:667599348183041@1536179496050/e-How-much-is-your-compound-worth-Biopharmaceutical-company-valuation-by-clinical-stage.png)
e How much is your compound worth? Biopharmaceutical company valuation... | Download Scientific Diagram
![Alector Headquarters in Silicon Valley. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Stock Photo - Image of information, alec: 174625493 Alector Headquarters in Silicon Valley. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Stock Photo - Image of information, alec: 174625493](https://thumbs.dreamstime.com/z/alector-headquarters-silicon-valley-inc-operates-as-clinical-stage-biopharmaceutical-company-south-san-francisco-california-174625493.jpg)
Alector Headquarters in Silicon Valley. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Stock Photo - Image of information, alec: 174625493
![Global clinical-stage biopharmaceutical company selects ValGenesis to digitize its corporate validation process Global clinical-stage biopharmaceutical company selects ValGenesis to digitize its corporate validation process](https://www.valgenesis.com/hubfs/Website/Press%20Releases/Global%20clinical-stage%20biopharmaceutical-optimized.jpg)
Global clinical-stage biopharmaceutical company selects ValGenesis to digitize its corporate validation process
![Alector Sign on HQ Facade. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Photo - Image of california, biotech: 179919146 Alector Sign on HQ Facade. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Photo - Image of california, biotech: 179919146](https://thumbs.dreamstime.com/b/alector-sign-hq-facade-inc-operates-as-clinical-stage-biopharmaceutical-company-south-san-francisco-california-usa-179919146.jpg)
Alector Sign on HQ Facade. Alector, Inc. Operates As a Clinical Stage Biopharmaceutical Company Editorial Photo - Image of california, biotech: 179919146
![New York-headquartered Clinical-stage Biopharmaceutical Company Zentalis Pharmaceuticals Has Closed A Series A Round At $20 Million To Fund The Establishment Of Joint Venture Zentera Therapeutics, The Company Announced In A Statement Earlier New York-headquartered Clinical-stage Biopharmaceutical Company Zentalis Pharmaceuticals Has Closed A Series A Round At $20 Million To Fund The Establishment Of Joint Venture Zentera Therapeutics, The Company Announced In A Statement Earlier](https://www.jumpstartmag.com/wp-content/uploads/2020/05/Zentalis.jpg)
New York-headquartered Clinical-stage Biopharmaceutical Company Zentalis Pharmaceuticals Has Closed A Series A Round At $20 Million To Fund The Establishment Of Joint Venture Zentera Therapeutics, The Company Announced In A Statement Earlier
![BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe - BerGenBio ASA BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe - BerGenBio ASA](https://mb.cision.com/Public/15728/2477716/a9e09d3f19a49082_800x800ar.jpg)
BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe - BerGenBio ASA
![GBT headquarters building facade and exterior. Global Blood Therapeutics is a clinical-stage biopharmaceutical company - South San Francisco, Californ Stock Photo - Alamy GBT headquarters building facade and exterior. Global Blood Therapeutics is a clinical-stage biopharmaceutical company - South San Francisco, Californ Stock Photo - Alamy](https://c8.alamy.com/comp/2GBK7AD/gbt-headquarters-building-facade-and-exterior-global-blood-therapeutics-is-a-clinical-stage-biopharmaceutical-company-south-san-francisco-californ-2GBK7AD.jpg)